Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Carbonic Anhydrase C, Antigen, Antiserum, Control

FDA product code DDE · 3 cleared devices

Class 1 Immunology
Regulation
21 CFR 866.5200
Review panel
HE
Implant
No
Life sustaining
No
Third party review
No
GMP exempt
No
Clearance span
1982-04-26 – 1990-07-10
↑